APT Medical is a leading manufacturer and supplier of EP and Vascular Intervention medical devices. Founded in 2002, APT Medical has established itself as a major global provider in the interventional medical field, focusing on advancing healthcare through technologies and innovations.
With a strong presence in over 90 countries and regions, APT Medical offers a diverse product portfolio covering Electrophysiology, Cardiology, Peripheral Intervention, and Neurointervention. The company has cultivated robust business relationships with clinicians, hospitals, and industries, reflecting its commitment to developing innovative products and solutions in collaboration with stakeholders.
The last investment in APT Medical was a CNY191.98M Venture Round infusion on 05 August 2019, led by Qiming Venture Partners. This investment underscores the confidence of the venture capital firm in APT Medical's potential for growth and innovation.
Consistently striving to empower clinicians to address clinical challenges with confidence, APT Medical remains dedicated to maintaining its position as a leader in the interventional field while prioritizing the health of humanity.